1. Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemia. (October 2020) Authors: Johansson, Patricia; Dierichs, Laura; Klein-Hitpass, Ludger; Bergmann, Anke K.; Möllmann, Michael; Menninger, Sascha; Habenberger, Peter; Klebl, Bert; Siveke, Jens T.; Dührsen, Ulrich; Choidas, Axel; Dürig, Jan Journal: Therapeutic advances in hematology Issue: Volume 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chemical Validation of DegS As a Target for the Development of Antibiotics with a Novel Mode of Action. (24th April 2019) Authors: Bongard, Jens; Schmitz, Anna Laura; Wolf, Alex; Zischinsky, Gunther; Pieren, Michel; Schellhorn, Birgit; Bravo‐Rodriguez, Kenny; Schillinger, Jasmin; Koch, Uwe; Nussbaumer, Peter; Klebl, Bert; Steinmann, Jörg; Buer, Jan; Sanchez‐Garcia, Elsa; Ehrmann, Michael; Kaiser, Markus Journal: ChemMedChem Issue: Volume 14:Number 11(2019) Page Start: 1074 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Discovery of a Novel Inhibitor of the Hedgehog Signaling Pathway through Cell‐based Compound Discovery and Target Prediction. (18th September 2017) Authors: Kremer, Lea; Schultz‐Fademrecht, Carsten; Baumann, Matthias; Habenberger, Peter; Choidas, Axel; Klebl, Bert; Kordes, Susanne; Schöler, Hans R.; Sterneckert, Jared; Ziegler, Slava; Schneider, Gisbert; Waldmann, Herbert Journal: Angewandte Chemie Issue: Volume 129:Number 42(2017) Page Start: 13201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Discovery of a Novel Inhibitor of the Hedgehog Signaling Pathway through Cell‐based Compound Discovery and Target Prediction. Issue 42 (18th September 2017) Authors: Kremer, Lea; Schultz‐Fademrecht, Carsten; Baumann, Matthias; Habenberger, Peter; Choidas, Axel; Klebl, Bert; Kordes, Susanne; Schöler, Hans R.; Sterneckert, Jared; Ziegler, Slava; Schneider, Gisbert; Waldmann, Herbert Journal: Angewandte Chemie international edition Issue: Volume 56:Issue 42(2017) Page Start: 13021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dynarrestin, a Novel Inhibitor of Cytoplasmic Dynein. Issue 4 (19th April 2018) Authors: Höing, Susanne; Yeh, Ting-Yu; Baumann, Matthias; Martinez, Nancy E.; Habenberger, Peter; Kremer, Lea; Drexler, Hannes C.A.; Küchler, Philipp; Reinhardt, Peter; Choidas, Axel; Zischinsky, Mia-Lisa; Zischinsky, Gunther; Nandini, Swaran; Ledray, Aaron P.; Ketcham, Stephanie A.; Reinhardt, Lydia; Abo... Journal: Cell chemical biology Issue: Volume 25:Issue 4(2018) Page Start: 357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Identification of an (−)‐englerin A analogue, which antagonizes (−)‐englerin A at TRPC1/4/5 channels. (25th January 2018) Authors: Rubaiy, Hussein N; Seitz, Tobias; Hahn, Sven; Choidas, Axel; Habenberger, Peter; Klebl, Bert; Dinkel, Klaus; Nussbaumer, Peter; Waldmann, Herbert; Christmann, Mathias; Beech, David J Journal: British journal of pharmacology Issue: Volume 175:Number 5(2018) Page Start: 830 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer. (16th October 2017) Authors: Lücking, Ulrich; Scholz, Arne; Lienau, Philip; Siemeister, Gerhard; Kosemund, Dirk; Bohlmann, Rolf; Briem, Hans; Terebesi, Ildiko; Meyer, Kirstin; Prelle, Katja; Denner, Karsten; Bömer, Ulf; Schäfer, Martina; Eis, Knut; Valencia, Ray; Ince, Stuart; von Nussbaum, Franz; Mumberg, Dominik; Ziegelbau... Journal: ChemMedChem Issue: Volume 12:Number 21(2017) Page Start: 1776 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Professional translational research: a new hybrid paradigm in early drug discovery. (September 2015) Authors: Nussbaumer, Peter; Klebl, Bert Journal: Future medicinal chemistry Issue: Volume 7:Number 14(2015) Page Start: 1879 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Sequence‐Selective Covalent CaaX‐Box Receptors Prevent Farnesylation of Oncogenic Ras Proteins and Impact MAPK/PI3 K Signaling. (19th May 2021) Authors: Franz, Matthias; Mörchen, Britta; Degenhart, Carsten; Gülden, Daniel; Shkura, Oleksandr; Wolters, Dirk; Koch, Uwe; Klebl, Bert; Stoll, Raphael; Helfrich, Iris; Scherkenbeck, Jürgen Journal: ChemMedChem Issue: Volume 16:Number 16(2021) Page Start: 2504 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Synthesis, Biological Evaluation, and Binding Mode of a New Class of Oncogenic K‐Ras4b Inhibitors. (23rd September 2022) Authors: Jeuken, Stephan; Shkura, Oleksandr; Röger, Marc; Brickau, Victoria; Choidas, Axel; Degenhart, Carsten; Gülden, Daniel; Klebl, Bert; Koch, Uwe; Stoll, Raphael; Scherkenbeck, Jürgen Journal: ChemMedChem Issue: Volume 17:Number 22(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗